2015-03-01

[DIV28SUPER] FDA: Women's History Month

http://www.fda.gov/aboutfda/whatwedo/history/ucm341839.htm

A recognition of women's contributions to FDA

Sent from my iPhone

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2015-02-28

[DIV28SUPER] 2015 Collaborative Perspectives on Addiction Meeting Information

 

Conference/Registration Information:

-          The conference will kick-off in the Hotel Monaco Baltimore at 12:45pm on Friday March 6th in the Paris Ballroom (3rd Floor).  http://research.alcoholstudies.rutgers.edu/cpa/schedule  

-          The registration desk will be in the Paris foyer (3rd Floor, outside of the Paris Ballroom) and will be open from 7am-5pm Friday and Saturday.

 

Continuing Education:

-          Sign-up information for receiving continuing education credits at the meeting (up to 12.25 CE credits) will be available at the registration desk. 

-          There is a $20 CE processing fee, which can be paid using cash, check or credit card.

 

Presentation Information:

-          Posters: The poster board format for the conference is horizontal (i.e., landscape) and the poster boards will be 4 feet tall by 6 feet wide (48” by 72”). 

-          Symposia:  Please bring a laptop with talks pre-loaded or a USB drive.  Projectors, screens, and microphones will be provided.  We will have AV support available to help.

Hotel Information:

Sign-up for the FREE Kimpton Karma Rewards guest loyalty program for special offers (including free internet) during your stay: https://www.kimptonhotels.com/karma-rewards/overview

 

Fitness Center: 24 hour access (located on the 3rd Floor)

 

(FREE) Wine Hour: Living Room, daily 5pm-6pm

 

(FREE) Coffee: Living Room, weekdays 6am-9am, weekends 7am-10am

 

Transportation Information:

Closest Airport:

  • Baltimore Washington International Airport (BWI)
    • Distance: ~10 miles
    • Cost of Taxi: ~$35

Transportation Companies:

Local Transportation:

Charm City Circulator: FREE transportation around the city (www.charmcitycirculator.com)

Baltimore Metro: Charles Street stop (directly across from hotel)

Light Rail: University Center-Baltimore Street stop (2 blocks away)

Downtown Parking Information: http://baltimore.bestparking.com/

 

 

We look forward to seeing everyone in Baltimore!

 

 

2015-02-20

[DIV28SUPER] ABCD FOAs Technical Assistance Webinar Feb 24, 2015, 1-2:30 PM EST: CHANGE IN WEBEX CONNECTION INFORMATION


This is a correction to the webex connection information for the ABCD pre-application technical assistance webinar, which will be conducted on Tuesday, February 24, 2015 from 1:00 to 2:30 p.m. EST to discuss the three new Adolescent Brain Cognitive Development (ABCD) Longitudinal Study funding opportunities: (1) a set of research project sites (
RFA-DA-15-015), (2) a single central data analysis and informatics center (RFA-DA-15-016), and (3) a single overall coordinating center (RFA-DA-15-014). 

 

The webinar will review the purpose and objectives of the funding opportunity announcements and will answer questions submitted by participants.  Participants may also submit questions ahead of time to:  AdolescentBrain@mail.nih.gov.

 

How to Participate in the Webinar

 

Event address: Join WebEx meeting

Topic: ABCD FOAs Technical Assistance Webinar  
Event number: 624 694 179
Event password: Success1!

For attendees who prefer to dial in and not view WebEx:

Call-in toll-free number (US/Canada): 1-877-668-4493
Call-in toll number (US/Canada): 1-650-479-3208
Access code: 624 045 509

 

Closed captioning will be provided.

 

Please direct all inquiries to:

John A. Matochik
National Institute on Alcohol Abuse and Alcoholism (
NIAAA)
Telephone: 301-451-7319
Email:
jmatochi@mail.nih.gov


Kevin Conway
National Institute on Drug Abuse (
NIDA)
Telephone: 301-402-1817

Email: kconway@nida.nih.gov

 

 

 The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.  Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact Jonathan D. Pollock, Ph.D.  jpollock@mail.nih.gov 301-435-1309

 

[DIV28SUPER] Papers for Special Issue on Sex Differences in Drug Abuse due March 16, 2015

Call for Papers: Experimental and Clinical Psychopharmacology

 

Special Issue for August 2015 on: Sex Differences in Drug Abuse: Etiology and Implications for Prevention and Treatment

 

The goal of this special issue is to broadly highlight how males and females differ in their risks for substance abuse, in their responses to treatments, and in their relapse to substance use after a period of abstinence. Relevant approaches include (but are not limited to) laboratory behavioral, social behavior and environmental context, brain development and function, and the role of genetics, hormones and neuropeptides. Both animal and human methods are appropriate for this issue. Collaborative manuscripts that bridge animal and human findings are especially valued.

 

This special issue is intended to showcase the importance of studying sex differences in drug abuse and how this research might lead to more tailored approaches for prevention and treatment. Laboratories engaged in research in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (www.apa.org/pubs/journals/pha/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on Sex Differences in Drug Abuse.  All submissions will undergo our normal peer review. Manuscripts received no later than March 16, 2015 will be considered for inclusion in the special issue. We strongly encourage individuals to contact us in advance with their ideas and ideally a draft title and abstract.

 

Questions or inquiries about the special issue can be directed to the Guest Editor of the issue, Brady Reynolds, PhD, at brady.reynolds@uky.edu or the Editor, Suzette Evans, PhD at se18@columbia.edu.


2015-02-17

[DIV28SUPER] Pre-Application Technical Assistance Webinar for RFAs for Adolescent Brain Cognitive Development (ABCD) Study, Feb. 24, 2015 from 1:30PM to 2:30PM EST

A Pre-Application Technical Assistance Webinar for RFA-DA-15-014 "ABCD Study - Coordinating Center (U24)", RFA-DA-15-015"ABCD Study - Research Project Sites (U01)", RFA-DA-15-016 "ABCD Study - Data Analysis and Informatics Center (U24)" will be held on Tuesday, February 24, 2015 from 1:00 to 2:30 p.m. EST.    http://grants.nih.gov/grants/guide/notice-files/NOT-DA-15-047.html

 

The purpose of this Notice is to inform the research community that a pre-application technical assistance webinar will be conducted on Tuesday, February 24, 2015 from 1:00 to 2:30 p.m. EDT to discuss the three new Adolescent Brain Cognitive Development (ABCD) Longitudinal Study funding opportunities.  The Collaborative Research on Addiction at the NIH (CRAN) and other NIH ICs intend to establish the Adolescent Brain Cognitive Development (ABCD) Study Consortium that consists of three integrated components: (1) a set of research project sites (RFA-DA-15-015), (2) a single central data analysis and informatics center (RFA-DA-15-016), and (3) a single overall coordinating center (RFA-DA-15-014). 

 

The webinar will review the purpose and objectives of the funding opportunity announcements and will answer questions submitted by participants.  Participants may also submit questions ahead of time to:  AdolescentBrain@mail.nih.gov.

 

All prospective applicants are invited to participate.

A second webinar may be held closer to the application deadline (April 14, 2015) if warranted.

How to Participate in the Webinar

Event address: https://nih.webex.com/nih/onstage/g.php?d=624045509&t=a 
Topic: ABCD FOAs Technical Assistance Webinar
Event number: 624 045 509
Event password: Success1!

For attendees who prefer to dial in and not view WebEx:
Call-in toll-free number (US/Canada): 1-877-668-4493
Call-in toll number (US/Canada): 1-650-479-3208
Access code: 624 045 509

Inquiries

Please direct all inquiries to:

John A. Matochik
National Institute on Alcohol Abuse and Alcoholism (
NIAAA)
Telephone: 301-451-7319
Email:
jmatochi@mail.nih.gov

Kevin Conway
National Institute on Drug Abuse (
NIDA)
Telephone: 301-402-1817

Email: kconway@nida.nih.gov

 

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.  Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

 

 

2015-02-13

[DIV28SUPER] Collaborative Perspectives on Addiction Meeting - Only three weeks away!

Trouble viewing this email? Visit our Website

 


2015 Collaborative Perspectives on Addiction
Baltimore Maryland
March 6-7, 2015

Reserve Your Hotel | Conference Registration | Final Program

 

 

ABOUT THE CONFERENCE

 

The theme for the 2015 CPA is "Changing Landscapes of Addiction: Use, Assessment and Treatment

·         Thought-provoking keynotes and cross-discipline panels

·         Interactive environment for collaboration/networking

·         Poster Sessions

·         Discounted rates for Early Career Psychologists

·         Student opportunities (discounted rates, special networking events)

·         You do not have to be a member of Division 50 or APA to attend the conference!

·         12.5 Continuing Education hours are available*!

 

MEET THE KEYNOTES

Carlo DiClemente, Ph.D., is a Professor of Psychology at the University of Maryland, Baltimore County.  He directs several Psychology Department Centers including the MDQUIT Tobacco Resource Center and the Center for Community Collaboration that are involved in state and national capacity building and SAMHSA funded projects on integrated care and SBIRT training and implementation.  Dr. DiClemente is the co-developer of the Transtheoretical Model of behavior change, and the author of numerous scientific publications on motivation and behavior change with a variety of health and addictive behaviors. Dr. DiClemente has co-authored a self-help book, Changing for Good, as well as several professional books, The Transtheoretical Model, Substance Abuse Treatment and the Stages of Change (second edition), and Group Treatment for Substance Abuse: A Stages of Change Therapy Manual.  His book, Addiction and Change: How Addictions Develop and Addicted People Recover, is published by Guilford Press. For his work in the addictions he was given the RWJF Innovators Combating Substance Abuse Award, the ASAM McGovern Award, a lifetime achievement award from ABCT’s Addictive Behavior Group, and a distinguished scientific contribution award from the American Psychological Association’s Division on Addictions.   

A. Thomas McLellan, Ph.D., is Chair of the Board and co-founder of the Treatment Research Institute (TRI) and an experienced substance abuse researcher. From 2009 to 2010, he was Science Advisor and Deputy Director of the White House Office of National Drug Control Policy (ONDCP), a Congressionally confirmed Presidential appointment to help shape the nation’s public policy approach to illicit drug use. At ONDCP, McLellan worked on a broad range of drug issues, including formulation and implementation of the President’s National Drug Control Strategy and promotion of drug treatment through the broader revamping of the national health care system. Dr. McLellan is the recipient of several distinguished awards including the Life Achievement Awards of the American and British Societies of Addiction Medicine; the RWJF Innovator Award; and awards for Distinguished Contribution to Addiction Medicine from the Swedish and Italian Medical Associations. With his at the University of Pennsylvania, Dr. McLellan introduced the Addiction Severity Index and, later, the Treatment Services Review. Both are among the most widely used assessment instruments in the world.

PRE-CONFERENCE WORKSHOPS  

We are currently offering four exciting pre-conference workshops, including three clinical workshops and one free workshop for students, post-docs, and early career psychologists.  Go to http://research.alcoholstudies.rutgers.edu/cpa/preconference for more information.

 

SYMPOSIA (1.25 CE credit each; 6.25 total)

 

We have an exciting lineup of sessions being offered at the CPA conference. Go to http://research.alcoholstudies.rutgers.edu/cpa/program to view full session descriptions.

 

POSTER SESSIONS

 

Last year’s poster session was the highlight of our networking events. This year, we will be hosting multiple poster sessions with concurrent networking receptions. 

HOTEL/VENUE

 

The beautiful Monaco Hotel in Baltimore will be the venue for our Annual Conference. The hotel is located in the heart of Baltimore and is local to public transportation. Reserve your room now!

 


MORE INFORMATION

 

Katie Witkiewitz, PhD, Program Chair

 

 

 

2015-02-12

[DIV28SUPER] NIDA Neuroscience Update February 13, 2015

 Table of Contents:


I.                    Adolescent Brain Cognitive Development Funding Opportunity Announcement

II.                  CPDD preconference grant writing workshop in Phoenix, Arizona on Friday, June 12, 2015

III.                Big Data to Knowledge (BD2K) Funding Opportunities

IV.               New BRAIN Initiative Funding Opportunities

V.                 RFA-DA-15-018 Developing Technologies and Tools to Monitor HIV Reservoirs and How they May be Altered by Exposure to Substance of Abuse (R21/R33)

VI.               17th Annual NIH SBIR/STTR;  Conference October 27 – 29, 2015;  Seattle, Washington

 

               

 

I.                    Adolescent Brain Cognitive Development Funding Opportunity Announcement

The goal of the Adolescent Brain Cognitive Development project is to establish a national, multisite, longitudinal cohort study to prospectively examine the neurodevelopmental and behavioral effects of substance use from early adolescence (approximately age 9-10) through the period of risk for substance use and substance use disorders.  Additional information about the ABCD project can be found on the Collaborative Research on Addiction at NIH (CRAN) website at: http://addictionresearch.nih.gov/.   

We look forward to hearing from you.

 

Please see the links below and note that the due date for applications is April 14, 2015. 

 

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-014.html

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-015.html

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-016.html

 

 

 

 

II.                  CPDD preconference grant writing workshop in Phoenix, Arizona on Friday, June 12, 2015

CPDD preconference grant writing workshop in Phoenix, Arizona on Friday, June 12, 2015 for early stage investigators (postdoc-junior faculty) as part of the NIDA Diversity Scholars Network (NDSN) program.  The NDSN is a rigorous and comprehensive mentorship program aimed at improving the funding of outstanding underrepresented early stage minority investigators in substance abuse research.

 

This meeting will provide scholars with information on NIDA's research funding priorities, grant development and review, research grant mechanisms, funding opportunity announcements, grant application/submission process, review and research/career tips.  Early stage investigators should be less than 10 years since receipt of their terminal degree or less than five years in the field of addictions research if the terminal degree was awarded more than 10 years ago.  In addition, applicants should be adequately positioned to submit an NIH research grant (i.e. R03, R21, R01) or Mentored Career Development Award (K) application within a year of the program date.

 

Interested applicants should email Albert Avila (aavila@nida.nih.gov) the following application materials in Word format as an email attachment by March 1, 2015:

 

·         E-mail subject line: CPDD 2015 NIDA Diversity Scholar Network Program

·         Attach a cover letter stating eligibility, interest in the program, description of research experience as they relate to substance abuse and addiction research, long-term professional research goals

·         Attach a detailed 2-3 page description of the proposed research concept for a future grant application; research concepts must be directly relevant to the NIDA mission and research goals (selectees may be required to submit a more detailed research proposal prior to the workshop)

·         Attach a recent curriculum vitae (list all NIH grant support if applicable)

·         Please include a current email and telephone number

 

The announcement contains program details, eligibility, and application information.  Feel free to contact Albert Avila at aavila@nida.nih.gov with questions.

 

 

III.                Big Data to Knowledge (BD2K) Funding Opportunities

Funding opportunities are available through NIH Big Data to Knowledge (BD2K) Initiative in the areas of Enhancing Training, and Analysis Methods and Software. 

For further information on BD2K and related funding opportunities see: www.bd2k.nih.gov

 

 

IV.                New BRAIN Initiative Funding Opportunities

Funding opportunities are available through Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative in the areas of large scale recording, novel approaches to understanding the nervous system and training in computational methods.  For further information on BRAIN and related

funding opportunities see: http://braininitiative.nih.gov/funding.htm

 

 

V.                 RFA-DA-15-018 Developing Technologies and Tools to Monitor HIV Reservoirs and How they May be Altered by Exposure to Substance of Abuse (R21/R33)

 

This R21/R33 FOA is designed to support research that will advance the goals of detecting and quantifying latent viral reservoirs in the brain, and whether substances of abuse can alter the latent viral reservoirs. The objective of this FOA is to support projects developing technologies and tools to detect, quantify, and characterize HIV brain reservoirs, including HIV within macrophage/microglia, astrocytes, or within specific brain regions, and how these reservoirs may be altered by exposure to substances of abuse. The ability to monitor and quantify latent HIV in living human brains is one of the ultimate goals of supporting this work. It is, therefore, necessary to either improve our ability to detect and quantify HIV latent reservoirs in living human brain, and/or examine potential biomarkers of latent infection in the brain to determine if substances of abuse modulate the characteristics of the reservoirs.  This initiative should help to establish important groundwork for the detection and eradication of HIV brain reservoirs in substance-abusing populations.

 

 

VI.               17th Annual NIH SBIR/STTR;  Conference October 27 – 29, 2015;  Seattle, Washington

The  17th Annual NIH SBIR/STTR Conference will be held on Tuesday, October 27 – Thursday, October 29, 2015, in Seattle, Washington. Hosted by the Washington State Department of Commerce (WSDC) (http://www.commerce.wa.gov/Pages/default.aspx), this event will be the largest annual gathering of HHS SBIR/STTR federal experts in the country, including representatives from NIH, CDC, FDA and others.

Washington State has a vibrant life science ecosystem making it an ideal location for our conference. The event will take place at Seattle's Destination Waterfront Venue, the Bell Harbor International Conference Center (http://www.bellharbor.com/).

Small businesses at any stage of the commercialization process are welcome to attend – whether you are an SBIR/STTR newcomer or have already reached commercial milestones and seeking outside investors, strategic partners or follow-on funding. We also welcome undergraduate and graduate students, women-owned small businesses and small disadvantaged businesses (https://sbir.nih.gov/about/women-owned). There will be sessions and workshops specifically designed to help you prepare and submit an application to HHS. 

 

Registration expected to open around May.

For more information contact

 

Kristopher Bough, PhD

Program Director, Division of Basic Neuroscience & Behavioral Research     

National Institute on Drug Abuse

6001 Executive Blvd – Rm 4271

Bethesda, MD 20892-9550

Office: 301-443-9800

Email: boughk@mail.nih.gov

 

Connect w/ the SBIR Program!

 

----


The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309